Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry
Purpose Symptom control for patients who were severely ill or dying from COVID-19 was paramount while resources were strained and infection control measures were in place. We aimed to describe the characteristics of SARS-CoV-2 infected patients who received specialized palliative care (SPC) and the type of SPC provided in a larger cohort. Methods From the multi-centre cohort study Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS), data of patients hospitalized with SARS-CoV-2 infection documented between July 2020 and October 2021 were analysed. Results 273/7292 patients (3.7%) received SPC. Those receiving SPC were older and suffered more often from comorbidities, but 59% presented with an estimated life expectancy > 1 year. Main symptoms were dyspnoea, delirium, and excessive tiredness. 224/273 patients (82%) died during the hospital stay compared to 789/7019 (11%) without SPC. Symptom control was provided most common (223/273; 95%), followed by family and psychological support (50% resp. 43%). Personal contact with friends or relatives before or during the dying phase was more often documented in patients receiving SPC compared to patients without SPC (52% vs. 30%). Conclusion In 3.7% of SARS-CoV-2 infected hospitalized patients, the burden of the acute infection triggered palliative care involvement. Besides complex symptom management, SPC professionals also focused on psychosocial and family issues and aimed to enable personal contacts of dying patients with their family. The data underpin the need for further involvement of SPC in SARS-CoV-2 infected patients but also in other severe chronic infectious diseases..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
|---|---|
| Enthalten in: |
Infection - 51(2023), 4 vom: 23. März, Seite 1119-1126 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schmidt-Hellerau, Kirsten [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
© The Author(s) 2023 |
|---|
| doi: |
10.1007/s15010-023-02020-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2144518408 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2144518408 | ||
| 003 | DE-627 | ||
| 005 | 20240118095504.0 | ||
| 007 | tu | ||
| 008 | 240118s2023 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-023-02020-z |2 doi | |
| 035 | |a (DE-627)OLC2144518408 | ||
| 035 | |a (DE-He213)s15010-023-02020-z-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 070 |a 610 |q VZ |
| 100 | 1 | |a Schmidt-Hellerau, Kirsten |e verfasserin |0 (orcid)0000-0003-4426-9565 |4 aut | |
| 245 | 1 | 0 | |a Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s) 2023 | ||
| 520 | |a Purpose Symptom control for patients who were severely ill or dying from COVID-19 was paramount while resources were strained and infection control measures were in place. We aimed to describe the characteristics of SARS-CoV-2 infected patients who received specialized palliative care (SPC) and the type of SPC provided in a larger cohort. Methods From the multi-centre cohort study Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS), data of patients hospitalized with SARS-CoV-2 infection documented between July 2020 and October 2021 were analysed. Results 273/7292 patients (3.7%) received SPC. Those receiving SPC were older and suffered more often from comorbidities, but 59% presented with an estimated life expectancy > 1 year. Main symptoms were dyspnoea, delirium, and excessive tiredness. 224/273 patients (82%) died during the hospital stay compared to 789/7019 (11%) without SPC. Symptom control was provided most common (223/273; 95%), followed by family and psychological support (50% resp. 43%). Personal contact with friends or relatives before or during the dying phase was more often documented in patients receiving SPC compared to patients without SPC (52% vs. 30%). Conclusion In 3.7% of SARS-CoV-2 infected hospitalized patients, the burden of the acute infection triggered palliative care involvement. Besides complex symptom management, SPC professionals also focused on psychosocial and family issues and aimed to enable personal contacts of dying patients with their family. The data underpin the need for further involvement of SPC in SARS-CoV-2 infected patients but also in other severe chronic infectious diseases. | ||
| 650 | 4 | |a Palliative care | |
| 650 | 4 | |a Pandemic | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Hospitalized patients | |
| 650 | 4 | |a Multicentre prospective cohort | |
| 650 | 4 | |a Infectious diseases | |
| 700 | 1 | |a Raichle, Claudia |0 (orcid)0000-0003-4452-0369 |4 aut | |
| 700 | 1 | |a Ruethrich, Maria M. |4 aut | |
| 700 | 1 | |a Vehreschild, Jörg J. |0 (orcid)0000-0002-5446-7170 |4 aut | |
| 700 | 1 | |a Lanznaster, Julia |0 (orcid)0000-0002-6592-156X |4 aut | |
| 700 | 1 | |a Nunes de Miranda, Susana M. |0 (orcid)0000-0003-2072-6979 |4 aut | |
| 700 | 1 | |a Bausewein, Claudia |0 (orcid)0000-0002-0958-3041 |4 aut | |
| 700 | 1 | |a Vehreschild, Maria J. G. T. |4 aut | |
| 700 | 1 | |a Koll, Carolin E. M. |0 (orcid)0000-0001-7940-3264 |4 aut | |
| 700 | 1 | |a Simon, Steffen T. |0 (orcid)0000-0002-6884-1813 |4 aut | |
| 700 | 1 | |a Hellwig, Kerstin |4 aut | |
| 700 | 1 | |a Jensen, Björn-Erik O. |0 (orcid)0000-0003-1626-4855 |4 aut | |
| 700 | 1 | |a Jung, Norma |0 (orcid)0000-0002-5740-0772 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d Springer Berlin Heidelberg, 1973 |g 51(2023), 4 vom: 23. März, Seite 1119-1126 |w (DE-627)129393010 |w (DE-600)185104-4 |w (DE-576)014777851 |x 0300-8126 |7 nnns |
| 773 | 1 | 8 | |g volume:51 |g year:2023 |g number:4 |g day:23 |g month:03 |g pages:1119-1126 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s15010-023-02020-z |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4305 | ||
| 951 | |a AR | ||
| 952 | |d 51 |j 2023 |e 4 |b 23 |c 03 |h 1119-1126 | ||